Reardon Andrew sold LGND
February 15, 2024 · Form 4 insider transaction
Reardon Andrew sold 593 shares of Ligand Pharmaceuticals Incorporated at $74.65 per share, a transaction worth $44.3K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
593
Price
$74.65
Total value
$44.3K
InsiderReardon Andrew
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 15, 2024
Filing dateFebruary 16, 2024
Shares owned after14,997
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.